News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Genepharm Australasia Ltd (GAA.AX)'s Cancer Drugs Approved By Therapeutic Goods Administration


3/9/2006 2:11:50 PM

San Francisco, March 9 (By Suvarna Bhatt, BioSpace) – Australian generics company, Genepharm Australasia announces marketing authorization approval from the Therapeutic Goods Administration (TGA) to sell its anti-cancer drugs, Epirubicin and Carboplatin as injectables in Australia. These are two of the leading drugs used in Australian hospitals for the treatment of cancer.

Read at BioSpace.com

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES